BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
ipca laboratories ltd stock

IPCA LABORATORIES LTD Share Price

1560.5 8.30 (0.53%)
Dec 12 2024 03:30 PM Pharmaceuticals NSE: IPCALAB

IPCA LABORATORIES LTD Share Price Update

As of the latest trading session, IPCA LABORATORIES LTD share price is currently at 1560.5, which is up by 8.30 from its previous closing. Today, the stock has fluctuated between 1555.00 and 1571.85. Over the past year, IPCA LABORATORIES LTD has achieved a return of 39.98 %. In the last month alone, the return has been 1.36 %. Read More...

IPCA LABORATORIES LTD Performance

Day Range

Low1555.00 High1571.85
1560.50

52 Week Range

Low 1041.00 High 1708.65
1560.50

IPCA LABORATORIES LTD Share Price

1633

524494

IPCALAB

img img img img
No Data Available

Open Price

1562.00

Prev. Close

1552.20

Volume (Shares)

571035.00

Total traded value

8911.00

Upper Circuit

1707.40

Lower Circuit

1397.00

Note: The current prices & values are delayed, Login to your account for live updates.

IPCA LABORATORIES LTD Fundamentals


(Standalone)

Market Cap (Cr) 39590.50
PE Ratio (TTM) 60.89
Book Value / Share 265.60
Beta 0.43
ROE 9.81%
EPS (TTM) 27.50
Dividend Yield 0.26%
Net Profit Qtr (Cr) 244.12

IPCA LABORATORIES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 1810.94
Operating Expense 1488.73
Net Profit 244.12
Net Profit Margin (%) 13.48
Earnings Per Share (EPS) 9.62
EBITDA 419.10
Effective Tax Rate (%) 28.03
Particulars JUN 2024 (Values in Cr)
Revenue 1565.86
Operating Expense 1293.36
Net Profit 204.13
Net Profit Margin (%) 13.03
Earnings Per Share (EPS) 8.05
EBITDA 368.63
Effective Tax Rate (%) 29.09
Particulars MAR 2024 (Values in Cr)
Revenue 1510.62
Operating Expense 1304.10
Net Profit 64.76
Net Profit Margin (%) 4.28
Earnings Per Share (EPS) 2.55
EBITDA 213.11
Effective Tax Rate (%) 49.12
Particulars DEC 2023 (Values in Cr)
Revenue 1506.83
Operating Expense 1324.02
Net Profit 136.94
Net Profit Margin (%) 9.08
Earnings Per Share (EPS) 5.40
EBITDA 290.38
Effective Tax Rate (%) 31.58
Particulars SEP 2023 (Values in Cr)
Revenue 1662.66
Operating Expense 1414.38
Net Profit 162.13
Net Profit Margin (%) 9.75
Earnings Per Share (EPS) 6.39
EBITDA 345.12
Effective Tax Rate (%) 33.85
Particulars MAR 2024 (Values in Cr)
Revenue 6166.46
Operating Expense 5322.23
Net Profit 530.41
Net Profit Margin (%) 8.60
Earnings Per Share (EPS) 20.91
EBITDA 1189.31
Effective Tax Rate (%) 35.48
Particulars MAR 2023 (Values in Cr)
Revenue 5814.62
Operating Expense 5175.32
Net Profit 505.70
Net Profit Margin (%) 8.69
Earnings Per Share (EPS) 19.93
EBITDA 1023.04
Effective Tax Rate (%) 32.61
Particulars MAR 2022 (Values in Cr)
Revenue 5438.30
Operating Expense 4417.11
Net Profit 860.37
Net Profit Margin (%) 15.82
Earnings Per Share (EPS) 33.91
EBITDA 1291.00
Effective Tax Rate (%) 19.89
Particulars MAR 2021 (Values in Cr)
Revenue 5139.16
Operating Expense 3821.44
Net Profit 1140.77
Net Profit Margin (%) 22.19
Earnings Per Share (EPS) 90.08
EBITDA 1575.82
Effective Tax Rate (%) 17.33
Particulars MAR 2020 (Values in Cr)
Revenue 4367.43
Operating Expense 3647.15
Net Profit 652.46
Net Profit Margin (%) 14.93
Earnings Per Share (EPS) 51.64
EBITDA 979.45
Effective Tax Rate (%) 16.88
Particulars MAR 2024 (Values in Cr)
Book Value / Share 249.59
ROE % 8.69
ROCE % 12.92
Total Debt to Total Equity 0.24
EBITDA Margin 17.40
Particulars MAR 2023 (Values in Cr)
Book Value / Share 230.27
ROE % 8.70
ROCE % 11.59
Total Debt to Total Equity 0.20
EBITDA Margin 16.90
Particulars MAR 2022 (Values in Cr)
Book Value / Share 215.41
ROE % 17.92
ROCE % 20.26
Total Debt to Total Equity 0.11
EBITDA Margin 23.66
Particulars MAR 2021 (Values in Cr)
Book Value / Share 370.65
ROE % 27.59
ROCE % 30.56
Total Debt to Total Equity 0.09
EBITDA Margin 29.71
Particulars MAR 2020 (Values in Cr)
Book Value / Share 286.15
ROE % 17.88
ROCE % 19.51
Total Debt to Total Equity 0.14
EBITDA Margin 20.85
Particulars MAR 2024 (Values in Cr)
Book Value / Share 250.24
ROE % 9.81
ROCE % 14.12
Total Debt to Total Equity 0.21
EBITDA Margin 21.08
Particulars MAR 2023 (Values in Cr)
Book Value / Share 231.66
ROE % 8.91
ROCE % 11.67
Total Debt to Total Equity 0.20
EBITDA Margin 17.64
Particulars MAR 2022 (Values in Cr)
Book Value / Share 215.84
ROE % 16.82
ROCE % 19.15
Total Debt to Total Equity 0.10
EBITDA Margin 23.80
Particulars MAR 2021 (Values in Cr)
Book Value / Share 374.67
ROE % 27.06
ROCE % 30.20
Total Debt to Total Equity 0.08
EBITDA Margin 30.72
Particulars MAR 2020 (Values in Cr)
Book Value / Share 290.11
ROE % 19.15
ROCE % 20.63
Total Debt to Total Equity 0.13
EBITDA Margin 22.50
Particulars MAR 2024 (Values in Cr)
Net Income 842.67
Cash from Operations 1240.95
Cash from Investing -1291.79
Cash from Financing -552.55
Net change in Cash -899.69
Free Cash Flow 1651.55
Particulars MAR 2023 (Values in Cr)
Net Income 745.29
Cash from Operations 1029.46
Cash from Investing -725.00
Cash from Financing 507.24
Net change in Cash 588.05
Free Cash Flow 1523.93
Particulars MAR 2022 (Values in Cr)
Net Income 1135.72
Cash from Operations 1058.11
Cash from Investing -855.05
Cash from Financing 426.78
Net change in Cash 427.80
Free Cash Flow 1537.06
Particulars MAR 2021 (Values in Cr)
Net Income 1388.98
Cash from Operations 1335.72
Cash from Investing -520.69
Cash from Financing -305.82
Net change in Cash 263.62
Free Cash Flow 1697.27
Particulars MAR 2020 (Values in Cr)
Net Income 738.89
Cash from Operations 722.57
Cash from Investing -509.65
Cash from Financing -136.54
Net change in Cash -75.84
Free Cash Flow 1028.85
Particulars MAR 2024 (Values in Cr)
Net Income 822.16
Cash from Operations 1107.46
Cash from Investing -1355.18
Cash from Financing -464.88
Net change in Cash -989.55
Free Cash Flow 1467.68
Particulars MAR 2023 (Values in Cr)
Net Income 750.49
Cash from Operations 977.54
Cash from Investing -709.61
Cash from Financing 506.38
Net change in Cash 559.06
Free Cash Flow 1414.40
Particulars MAR 2022 (Values in Cr)
Net Income 1074.11
Cash from Operations 1023.88
Cash from Investing -814.00
Cash from Financing 426.04
Net change in Cash 443.76
Free Cash Flow 1475.51
Particulars MAR 2021 (Values in Cr)
Net Income 1379.96
Cash from Operations 1337.93
Cash from Investing -559.56
Cash from Financing -307.38
Net change in Cash 229.12
Free Cash Flow 1687.58
Particulars MAR 2020 (Values in Cr)
Net Income 784.97
Cash from Operations 707.84
Cash from Investing -499.13
Cash from Financing -138.67
Net change in Cash -76.37
Free Cash Flow 980.91
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 37.45 3.55 499.34 37.54 / 77.70
BLISS GVS PHARMA LTD 151.80 19.00 1.58 1598.94 92.25 / 172.40
CIPLA LTD 1454.20 25.44 4.14 117443.01 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 410.00 142.36 4.15 1206.67 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 56.66 11.07 499.34 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.55 45.59 7.27 2167.00 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6595.05 128.08 24.26 16487.63 4050.15 / 8139.85
BLISS GVS PHARMA LTD 151.80 19.79 1.56 1598.94 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1530.10
  • 26 Days 1548.10
  • 10 Days 1527.40
  • 50 Days 1544.60
  • 12 Days 1538.20
  • 100 Days 1477.50
  • 20 Days 1534.30
  • 200 Days 1257.70
1546.17
PIVOT
First Resistance 1564.03
Second Resistance 1575.87
Third Resistance 1593.73
First Support 1534.33
Second Support 1516.47
Third Support 1504.63
RSI 51.69
MACD -9.95
Commodity Channel Index (CCI) 8.75
ADX 15.16
Williams % R -46.00

Over 1 Month

down

1.36

Over 3 Months

down

8.08

Over 6 Months

down

32.24

Over 1 Year

down

39.98

Over 3 Years

down

15.10

Over 5 Years

down

22.13

IPCA LABORATORIES LTD Future

Future: Price

26 Dec
1559.70
30 Jan
1570.00
25 May
0 100 200 300 400 500 600

Discount/Premium

26 Dec
-0.80
30 Jan
9.50
25 May
0 1 2 3 4 5 6 7

Active Calls

1560.0
1542
1600.0
977
1620.0
633
25 May
0 500 1000 1500 2000 2500 3000

Active Puts

1560.0
229
1500.0
208
1540.0
136
25 Jul
0 500 1000 1500 2000 2500

IPCA LABORATORIES LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
8.64
Promoter Holdings
46.3
FII
10.83
DII
34.22
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Kaygee Investments Private Limited Shareholding of Promoter and Promoter Group 5.447839E7 21.47
Hdfc Mutual Fund - Hdfc Mid-cap Opportunities Fund Public Shareholding 2.3197104E7 9.14
Kaygee Laboratories Private Limited Shareholding of Promoter and Promoter Group 1.677E7 6.61
Dsp Midcap Fund Public Shareholding 1.5145041E7 5.97
Chandurkar Investments Private Limited Shareholding of Promoter and Promoter Group 1.395601E7 5.5
Kotak Emerging Equity Scheme Public Shareholding 1.3005448E7 5.13
Paschim Chemicals Pvt Ltd Shareholding of Promoter and Promoter Group 1.0173E7 4.01
Usha M Chandurkar Shareholding of Promoter and Promoter Group 8302000.0 3.27
Premchand Godha Shareholding of Promoter and Promoter Group 5814680.0 2.29
Sbi Life Insurance Co. Ltd Public Shareholding 5589028.0 2.2
Hdfc Life Insurance Company Limited Public Shareholding 4903819.0 1.93
Nippon Life India Trustee Ltd-a/c Nippon India Growth Fund Public Shareholding 4856633.0 1.91
Parag Parikh Flexi Cap Fund Public Shareholding 3716750.0 1.46
Kotak Funds - India Midcap Fund Public Shareholding 3450394.0 1.36
Usha Premchand Godha Shareholding of Promoter and Promoter Group 2418740.0 0.95
Sameer M Chandurkar Shareholding of Promoter and Promoter Group 2000000.0 0.79
Pranay Godha Shareholding of Promoter and Promoter Group 1700990.0 0.67
Prashant Godha Shareholding of Promoter and Promoter Group 1568644.0 0.62
Kalpana Jain Shareholding of Promoter and Promoter Group 230000.0 0.09
Mexin Medicaments Private Limited Shareholding of Promoter and Promoter Group 14058.0 0.01
Xbees Traders Llp Shareholding of Promoter and Promoter Group 31000.0 0.01
Makers Laboratories Limited Shareholding of Promoter and Promoter Group 960.0 0.0
Nirmal Jain Shareholding of Promoter and Promoter Group 0.0 0.0
Neetu Godha Shareholding of Promoter and Promoter Group 4000.0 0.0
Bhawna Godha Shareholding of Promoter and Promoter Group 5000.0 0.0

IPCA LABORATORIES LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-11-22 2.0 Interim 2023-11-22 Equity shares 2022-11-22 4.0 Interim 2022-11-23 Equity shares 2021-11-22 8.0 Interim 2021-11-23 Equity shares 2020-11-13 8.0 Interim 2020-11-17 Equity shares 2020-02-18 5.0 Interim 2020-02-20 Equity shares 2019-08-06 3.0 Final 2019-08-08 Equity shares 2018-08-02 1.0 Final 2018-08-04 Equity shares 2017-07-27 1.0 Final 2017-07-29 Equity shares 2015-07-22 1.0 Final 2015-07-24 Equity shares 2014-07-18 2.5 Final 2014-07-22 Equity shares 2013-10-31 2.5 Interim 2013-11-01 Equity shares 2013-07-19 2.0 Final 2013-07-23 Equity shares 2012-11-01 2.0 Interim 2012-11-02 Equity shares 2012-07-20 1.2 Final 2012-07-24 Equity shares 2012-02-07 1.0 Interim 2 2012-02-08 Equity shares 2011-11-03 1.0 Interim 2011-11-07 Equity shares 2011-07-18 1.2 Final 2011-07-20 Equity shares 2011-02-01 1.0 Interim 2 2011-02-02 Equity shares 2010-10-28 1.0 Interim 2010-10-29 Equity shares 2010-07-16 1.0 Final 2010-07-20 Equity shares 2010-01-27 4.0 Interim 2 2010-01-28 Equity shares 2009-10-30 5.0 Interim 2009-11-03 Equity shares 2009-07-20 4.0 Final 2009-07-22 Equity shares 2009-01-27 3.0 Interim 2 2009-01-28 Equity shares 2008-11-07 4.0 Interim 2008-11-10 Equity shares 2008-07-14 4.5 Final 2008-07-16 Equity shares 2007-11-06 3.5 Interim 2007-11-07 Equity shares 2007-07-10 4.0 Final 2007-07-12 Equity shares 2006-11-02 3.5 Interim 0001-01-01 Equity shares 2005-11-09 0.0 Interim 2005-11-10 Equity shares 2005-09-13 0.0 Final 2005-09-15 Equity shares
Ex-Date Ex-Bonus Ratio
2005-01-31 2005-01-28 1:1
Ex-Date Old FV NEW FV Record Date
2022-01-10 2.0 1.0 2022-01-11 2010-03-22 10.0 2.0 2010-03-23

Learn More About Stocks

About IPCA LABORATORIES LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by IPCA LABORATORIES LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Ipca Laboratories Ltd?

Answer Field

The share price of Ipca Laboratories Ltd for NSE is ₹ 1560.5 and for BSE is ₹ 1555.

What is the Market Cap of Ipca Laboratories Ltd?

Answer Field

The market cap of Ipca Laboratories Ltd for NSE is ₹ 3,95,90.50 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Ipca Laboratories Ltd?

Answer Field

The 52 Week High and Low of Ipca Laboratories Ltd for NSE is ₹ 1708.65 and ₹ 1041.00 and for BSE is ₹ 1708.70 and ₹ 1042.00.

How to Buy Ipca Laboratories Ltd share?

Answer Field

You can trade in Ipca Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Ipca Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 39.98%.

What is the Current Share Price of Ipca Laboratories Ltd?

Answer Field

Ipca Laboratories Ltd share price is for NSE ₹ 1560.5 & for BSE ₹ 1555 as on Dec 12 2024 03:30 PM.

What is the Market Cap of Ipca Laboratories Ltd Share?

Answer Field

The market cap of Ipca Laboratories Ltd for NSE ₹ 3,95,90.50 & for BSE ₹ 0.0 as on Dec 12 2024 03:30 PM.

What is the P/E Ratio of Ipca Laboratories Ltd Share?

Answer Field

As on Dec 12 2024 03:30 PM the price-to-earnings (PE) ratio for Ipca Laboratories Ltd share is 60.89.

What is the PB ratio of Ipca Laboratories Ltd Share?

Answer Field

As on Dec 12 2024 03:30 PM, the price-to-book (PB) ratio for Ipca Laboratories Ltd share is 265.60.

How to Buy Ipca Laboratories Ltd Share?

Answer Field

You can trade in Ipca Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Ipca Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Ipca Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Ipca Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader